ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis

Luo, Qimei; Liu, Mi; Tan, Yanhong; Chen, Jinzhong; Zhang, Wei; Zhong, Shaoxin; Pan, Jianyi; Zheng, Qingkun; Gong, Lewei; Su, Lijuan; Jia, Zhanjun*; Dou, Xianrui*南方医科大学; 1
Frontiers in Pharmacology2022-11-11DOI: 10.3389/fphar.2022.1004619
1被引5阅读
引用收藏
分享

摘要

Inflammatory responses in the peritoneum contribute to peritoneal dialysis (PD)-associated peritoneal fibrosis. Results of our previous study showed that increased microsomal prostaglandin E synthase-1-mediated production of prostaglandin E2 (PGE2) contributed to peritoneal fibrosis. However, the role of its downstream receptor in the progression of peritoneal fibrosis has not been established. Here, we examined the role of PGE2 receptor 4 (EP4) in the development of peritoneal fibrosis. EP4 was significantly upregulated in peritoneal tissues of PD patients with ultrafiltration failure, along with the presence of an enhanced inflammatory response. In vitro experiments showed that exposure to high glucose concentrations enhanced EP4 expression in rat peritoneal mesothelial cells (RPMCs). High-glucose-induced expression of inflammatory cytokines (monocyte chemoattractant protein-1, tumour necrosis factor alpha, and interleukin 1 beta) was significantly reduced in RPMCs treated with ONO-AE3-208, an EP4 receptor antagonist. ONO-AE3-208 also significantly decreased the expression of extracellular matrix proteins induced by high glucose concentrations. Furthermore, ONO-AE3-208 blunted activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome and phosphorylation of nuclear factor kappa B (NF-kappa B) (p-p65). To further investigate the functional role of EP4, ONO-AE3-208 was administrated for 4 weeks in a rat model of PD, the results of which showed that ONO-AE3-208 inhibited peritoneal fibrosis and improved peritoneal dysfunction. Additionally, inflammatory cytokines in the peritoneum of PD rats treated with ONO-AE3-208 were downregulated, in line with inhibition of the NLRP3 inflammasome and NF-kappa B phosphorylation. In conclusion, an EP4 antagonist reduced the development of peritoneal fibrosis, possibly by suppressing NLRP3 inflammasome- and p-p65-mediated inflammatory responses. Our findings suggest that an EP4 antagonist may be therapeutically beneficial for PD-associated peritoneal fibrosis.

学科与关键词

关键词
prostaglandin E2 receptor 4ONO-AE3-208peritoneal dialysisfibrosisinflammation
相关
加载中…
  • Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome
    Luo, Qimei; Hu, Qinghua; Zheng, Qingkun; Gong, Lewei; Su, Lijuan; Ren, Baojun; Ju, Yongle; Jia, Zhanjun*; Dou, Xianrui*Frontiers in Medicine, 2021, 8: 675363.被引 9
  • PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation
    Feng, Junxia; Lu, Meizhi; Li, Wenhao; Li, Jingchun; Meng, Ping; Li, Zukai; Gao, Xuejuan*; Zhang, Yunfang*Molecular and Cellular Biochemistry, 2022, 477(7): 1959-1971.被引 5
  • Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-κB/ TGF-β/Smad signaling axis
    Zhang, Ying; Feng, Weidong; Peng, Xuan; Zhu, Liya; Wang, Zebin; Shen, Hua; Chen, Chaojiang; Xiao, Long; Li, Shuting; Zhao, Yunyi; Lin, Muyi; Huang, Ying*; Long, Haibo*; Liang, Jianbo*Laboratory Investigation, 2022, 102(12): 1346-1354.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-11
卷期
第 13 卷
页码
1004619
DOI
10.3389/fphar.2022.1004619
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation for Yong Scholars of China [81800674]; Natural Science Foundation of Guangdong Province [2018A030310428]; China Postdoctoral Science Foundation [2019M663006]; Scientific Research Start Plan of Shunde Hospital, Southern Medical University [SRSP2019007]

作者

  • L

    Luo, Qimei (第一作者)

    1 · southern med univ

  • L

    Liu, Mi

    1 · southern med univ

查看全部 12 位作者收起作者
  • T

    Tan, Yanhong

    1 · southern med univ

  • C

    Chen, Jinzhong

    1 · southern med univ

  • Z

    Zhang, Wei

    1 · southern med univ

  • Z

    Zhong, Shaoxin

    1 · southern med univ

  • P

    Pan, Jianyi

    1 · southern med univ

  • Z

    Zheng, Qingkun

    1 · southern med univ

  • G

    Gong, Lewei

    1 · southern med univ

  • S

    Su, Lijuan

    1 · southern med univ

  • J

    Jia, Zhanjun (通讯)

    nanjing med univ

  • D

    Dou, Xianrui (通讯)

    1 · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417